208 related articles for article (PubMed ID: 28270296)
1. Multidetector CT for Restaging Locally Advanced Esophageal Squamous Cell Carcinoma and Assessing Therapeutic Response to Neoadjuvant Chemotherapy.
Shi Y; Chen Y; Li X; Wang Z; Sun Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):133-139. PubMed ID: 28270296
[TBL] [Abstract][Full Text] [Related]
2. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
Griffin JM; Reed CE; Denlinger CE
Ann Thorac Surg; 2012 Jun; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
[TBL] [Abstract][Full Text] [Related]
3. Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade.
Djuric-Stefanovic A; Micev M; Stojanovic-Rundic S; Pesko P; Saranovic Dj
Eur J Radiol; 2015 Dec; 84(12):2477-84. PubMed ID: 26467704
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer.
Konieczny A; Meyer P; Schnider A; Komminoth P; Schmid M; Lombriser N; Weishaupt D
Eur Radiol; 2013 Sep; 23(9):2492-502. PubMed ID: 23645329
[TBL] [Abstract][Full Text] [Related]
5. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
[TBL] [Abstract][Full Text] [Related]
6. Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus.
Dewan A; Sharma SK; Dewan AK; Khurana R; Gupta M; Pahuja A; Srivastava H; Sinha R
J Gastrointest Cancer; 2017 Mar; 48(1):42-49. PubMed ID: 27604122
[TBL] [Abstract][Full Text] [Related]
7. The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Song T; Yao Q; Qu J; Zhang H; Zhao Y; Qin J; Feng W; Zhang S; Han X; Wang S; Yan X; Li H
Eur Radiol; 2021 Mar; 31(3):1391-1400. PubMed ID: 32901300
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation.
Isenberg G; Chak A; Canto MI; Levitan N; Clayman J; Pollack BJ; Sivak MV
Gastrointest Endosc; 1998 Aug; 48(2):158-63. PubMed ID: 9717781
[TBL] [Abstract][Full Text] [Related]
9. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
10. The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer.
Lu Y; Ma L; Qin J; Wang Z; Guo J; Zhao Y; Zhang H; Yan X; Liu H; Li H; Kamel IR; Qu J
BMC Cancer; 2019 Oct; 19(1):999. PubMed ID: 31651280
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
Oda S; Kuno H; Hiyama T; Sakashita S; Sasaki T; Kobayashi T
Abdom Radiol (NY); 2023 Aug; 48(8):2503-2513. PubMed ID: 37171586
[TBL] [Abstract][Full Text] [Related]
12. Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results.
Hayano K; Okazumi S; Shuto K; Matsubara H; Shimada H; Nabeya Y; Kazama T; Yanagawa N; Ochiai T
Oncol Rep; 2007 Oct; 18(4):901-8. PubMed ID: 17786353
[TBL] [Abstract][Full Text] [Related]
13. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
[TBL] [Abstract][Full Text] [Related]
14. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.
Cao XF; He XT; Ji L; Xiao J; Lv J
Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071
[TBL] [Abstract][Full Text] [Related]
15. Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).
Miyata H; Yamasaki M; Takahashi T; Murakami K; Tanaka K; Yukinori K; Nakajima K; Takiguchi S; Morii E; Hatazawa J; Mori M; Doki Y
Ann Surg Oncol; 2014 Feb; 21(2):575-82. PubMed ID: 24201746
[TBL] [Abstract][Full Text] [Related]
16. A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy.
Mesenas S; Vu C; McStay M; Forshaw M; Doig L; Mason R; Boyle N; Meenan J
Dis Esophagus; 2008; 21(1):37-42. PubMed ID: 18197937
[TBL] [Abstract][Full Text] [Related]
17. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
18. CT Signs Can Predict Treatment Response and Long-Term Survival: A Study in Locally Advanced Esophageal Cancer with Preoperative Chemotherapy.
Zhang XY; Yan WP; Sun Y; Li XT; Chen Y; Fan MY; Wu Y; Liang Z; Xiong HC; Wang ZL; Sun YS; Chen KN
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1380-7. PubMed ID: 25940570
[TBL] [Abstract][Full Text] [Related]
19. International survey on esophageal cancer: part II staging and neoadjuvant therapy.
Boone J; Livestro DP; Elias SG; Borel Rinkes IH; van Hillegersberg R
Dis Esophagus; 2009; 22(3):203-10. PubMed ID: 19191855
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between Standardized Uptake Value in Preneoadjuvant and Postneoadjuvant Chemoradiotherapy and Tumor Regression Grade in Patients With Locally Advanced Esophageal Cancer.
Baksh K; Prithviraj G; Kim Y; Hoffe S; Shridhar R; Coppola D; Centeno B; Pimiento J; Meredith K; Almhanna K
Am J Clin Oncol; 2018 Mar; 41(3):254-258. PubMed ID: 26703814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
